A Phase1b/2 Study Assessing Safety and Anti-tumour Activity of AMG 820 in Combination With Pembrolizumab in Select Advanced Solid Tumours
A multi-centre Phase 1b/2 study testing the combination of AMG 820 and pembrolizumab in
subjects with select advanced solid tumours.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society